The document summarizes GlobalMed Technologies, a company that developed an ultraviolet light blood irradiation system to treat HIV/AIDS. It details the need for alternative treatments given drug resistance issues. The system was tested in clinical trials in the Dominican Republic that significantly reduced viral loads and increased life expectancy. GlobalMed is seeking funding to conduct phase 2 clinical trials in Colombia on 200 patients to further validate the treatment and ultimately seek approval and market it globally as a more effective and lower-cost alternative to existing antiretroviral drugs.
AVIcure Bioscience is seeking $20 million in funding to conduct clinical trials for their flagship medical device, the ImmunoModulatorTM. The device uses ultraviolet blood irradiation (UVBI) technology to treat blood-borne diseases like Crohn's Disease. UVBI has been shown to inactivate pathogens by preventing their replication through molecular damage to DNA/RNA. The chair and co-founder, Dr. Kuenstner, developed the device to find a cure for Crohn's Disease after family members suffered from it. The ImmunoModulatorTM was designed over 5 years incorporating patented engineering innovations to safely and effectively treat blood outside the body using optimized UV wavelengths. Previous studies indicate the device mitigates symptoms
AVIcure Bioscience develops and markets patented medical devices using ultraviolet light technology. It has 8 employees and is located in Bethlehem, PA. It focuses on blood pathogen reduction, immune system stimulation, and pain relief. Its products include the HemaSterilizer blood pathogen reduction device, ImmunoModulator for immune system stimulation, and AVIcure device for pain relief. It has a strong IP position and management team with expertise in science and business.
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...Jake Chen
: COVID-19 has profoundly impacted all our lives. Not all such impacts in science are negative. For example, how we adapt to online learning, remote mentorship, and online teamwork may become new “norms” of future scientific collaborations, breaking down institutional boundaries to communication. The COVID-19 pandemic has united the scientific community more than ever, through more than 3600 clinical trials, 60,000 peer-reviewed publications, 80,000 SARS-CoV-2 genome sequences, 100,000 COVID-19 open software tools, and a global community of scientists, with which all of us are working hard to find epidemiological patterns, diagnosis, therapeutics, and vaccines in a “War Against COVID-19”. In this talk, I will define and characterize data-driven medicine primarily through my personal journey in the past ten months, having witnessed the rapid “weaponizing of data science tools” in our community’s fight against COVID-19 (including ours, at http://covid19.ubrite.org/). I will review up-to-date COVID-19 literature, especially those related to how biomedical informatics, data science, and artificial intelligence have been applied in accelerating COVID-19 breakthrough discoveries, from basic research to clinical practice. I will end by sharing my thoughts on how the future of medicine in cancer and other translational areas can benefit from the proactive incorporation of new “data science engines.”
- GeoVax Labs is developing both preventative and therapeutic HIV/AIDS vaccines using DNA and MVA technologies exclusively licensed from Emory University.
- Their preventative vaccine has completed a Phase 2a trial and plans to begin a Phase 2b efficacy trial in 2013. Their therapeutic vaccine is currently enrolling patients in a Phase 1/2 trial.
- Both vaccines have shown compelling results in pre-clinical studies, inducing antibody and T-cell immune responses against HIV.
Medical application of ultrasound began post World War II in the 1940s, with the first diagnostic application being in cardiology and brain tumor identification. Today ultrasound has medical applications in every area of the body and gives accurate results regarding overall structural composition, based on the density and transmission of the sound waves through biological tissue. Along with the conventional black and white ultrasound imaging systems, the global market also has high potential for color Doppler and 3D/4D imaging systems. The imaging clarity and diagnostic abilities offered by recent ultrasound devices is predicted to give a thrust to the overall global diagnostic market; this will also support other imaging technologies such as Magnetic Resonance Imaging, Computed Tomography, and PET/SPECT.
Disease monitoring in wheat through remotely sensed dataCIMMYT
Remote sensing –Beyond images
Mexico 14-15 December 2013
The workshop was organized by CIMMYT Global Conservation Agriculture Program (GCAP) and funded by the Bill & Melinda Gates Foundation (BMGF), the Mexican Secretariat of Agriculture, Livestock, Rural Development, Fisheries and Food (SAGARPA), the International Maize and Wheat Improvement Center (CIMMYT), CGIAR Research Program on Maize, the Cereal System Initiative for South Asia (CSISA) and the Sustainable Modernization of the Traditional Agriculture (MasAgro)
Viatar is a medtech company focused on developing products to treat cancer patients. Its lead product, the Viatar Therapeutic Oncopheresis System, removes circulating tumor cells from blood to improve cancer outcomes. Animal studies show removing CTCs can slow cancer progression and increase survival. The system may address a $1.5 billion market. Viatar is also developing liquid biopsy products to collect CTCs for cancer screening and research. The company expects to begin commercializing products in Europe in late 2016 and the US after additional clinical trials.
التقدم في تكنولوجيا المعلومات للكشف عن أمراض النباتات Advances in Informatio...Mohamed Mostafa
This document discusses advances in information technology for detecting plant diseases. It outlines how machine learning techniques and expert systems can be used to identify plant diseases early. Remote sensing using hyperspectral sensors and wireless sensor networks are also presented as methods to continuously monitor crops for stress or disease. The conclusion states that sensory-based information and communication technologies can help experts more accurately detect problems affecting crops.
AVIcure Bioscience is seeking $20 million in funding to conduct clinical trials for their flagship medical device, the ImmunoModulatorTM. The device uses ultraviolet blood irradiation (UVBI) technology to treat blood-borne diseases like Crohn's Disease. UVBI has been shown to inactivate pathogens by preventing their replication through molecular damage to DNA/RNA. The chair and co-founder, Dr. Kuenstner, developed the device to find a cure for Crohn's Disease after family members suffered from it. The ImmunoModulatorTM was designed over 5 years incorporating patented engineering innovations to safely and effectively treat blood outside the body using optimized UV wavelengths. Previous studies indicate the device mitigates symptoms
AVIcure Bioscience develops and markets patented medical devices using ultraviolet light technology. It has 8 employees and is located in Bethlehem, PA. It focuses on blood pathogen reduction, immune system stimulation, and pain relief. Its products include the HemaSterilizer blood pathogen reduction device, ImmunoModulator for immune system stimulation, and AVIcure device for pain relief. It has a strong IP position and management team with expertise in science and business.
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...Jake Chen
: COVID-19 has profoundly impacted all our lives. Not all such impacts in science are negative. For example, how we adapt to online learning, remote mentorship, and online teamwork may become new “norms” of future scientific collaborations, breaking down institutional boundaries to communication. The COVID-19 pandemic has united the scientific community more than ever, through more than 3600 clinical trials, 60,000 peer-reviewed publications, 80,000 SARS-CoV-2 genome sequences, 100,000 COVID-19 open software tools, and a global community of scientists, with which all of us are working hard to find epidemiological patterns, diagnosis, therapeutics, and vaccines in a “War Against COVID-19”. In this talk, I will define and characterize data-driven medicine primarily through my personal journey in the past ten months, having witnessed the rapid “weaponizing of data science tools” in our community’s fight against COVID-19 (including ours, at http://covid19.ubrite.org/). I will review up-to-date COVID-19 literature, especially those related to how biomedical informatics, data science, and artificial intelligence have been applied in accelerating COVID-19 breakthrough discoveries, from basic research to clinical practice. I will end by sharing my thoughts on how the future of medicine in cancer and other translational areas can benefit from the proactive incorporation of new “data science engines.”
- GeoVax Labs is developing both preventative and therapeutic HIV/AIDS vaccines using DNA and MVA technologies exclusively licensed from Emory University.
- Their preventative vaccine has completed a Phase 2a trial and plans to begin a Phase 2b efficacy trial in 2013. Their therapeutic vaccine is currently enrolling patients in a Phase 1/2 trial.
- Both vaccines have shown compelling results in pre-clinical studies, inducing antibody and T-cell immune responses against HIV.
Medical application of ultrasound began post World War II in the 1940s, with the first diagnostic application being in cardiology and brain tumor identification. Today ultrasound has medical applications in every area of the body and gives accurate results regarding overall structural composition, based on the density and transmission of the sound waves through biological tissue. Along with the conventional black and white ultrasound imaging systems, the global market also has high potential for color Doppler and 3D/4D imaging systems. The imaging clarity and diagnostic abilities offered by recent ultrasound devices is predicted to give a thrust to the overall global diagnostic market; this will also support other imaging technologies such as Magnetic Resonance Imaging, Computed Tomography, and PET/SPECT.
Disease monitoring in wheat through remotely sensed dataCIMMYT
Remote sensing –Beyond images
Mexico 14-15 December 2013
The workshop was organized by CIMMYT Global Conservation Agriculture Program (GCAP) and funded by the Bill & Melinda Gates Foundation (BMGF), the Mexican Secretariat of Agriculture, Livestock, Rural Development, Fisheries and Food (SAGARPA), the International Maize and Wheat Improvement Center (CIMMYT), CGIAR Research Program on Maize, the Cereal System Initiative for South Asia (CSISA) and the Sustainable Modernization of the Traditional Agriculture (MasAgro)
Viatar is a medtech company focused on developing products to treat cancer patients. Its lead product, the Viatar Therapeutic Oncopheresis System, removes circulating tumor cells from blood to improve cancer outcomes. Animal studies show removing CTCs can slow cancer progression and increase survival. The system may address a $1.5 billion market. Viatar is also developing liquid biopsy products to collect CTCs for cancer screening and research. The company expects to begin commercializing products in Europe in late 2016 and the US after additional clinical trials.
التقدم في تكنولوجيا المعلومات للكشف عن أمراض النباتات Advances in Informatio...Mohamed Mostafa
This document discusses advances in information technology for detecting plant diseases. It outlines how machine learning techniques and expert systems can be used to identify plant diseases early. Remote sensing using hyperspectral sensors and wireless sensor networks are also presented as methods to continuously monitor crops for stress or disease. The conclusion states that sensory-based information and communication technologies can help experts more accurately detect problems affecting crops.
Nanotechnology is the science of understanding, inventing, and controlling objects which are built in the scales of nanometers (one nanometer is one-billionth of a meter). Using Nanotechnology, manufacturers can compose components such as batteries, robots, or tools at a very small scale which may be later added to medical devices. With advanced scientific developments over a decade, Nanotechnology is proving itself to be useful in the healthcare domain including alternative drug production, cosmetic products, and medical devices. As, in such cases, human safety is the highest priority, these devices or applications which utilize Nanotechnology should be FDA compliant before they are marketed for use...
Human Ad-5 based FMD vaccines (T. de Los Santos)EuFMD
The European Commission for the Control of Foot-and-Mouth Disease (EuFMD), one of FAO’s oldest Commissions, came into being on the 12th June 1954, with the pledge of the sixth founding member state to the principles of a coordinated and common action against Foot-and-mouth Disease.
The document discusses the safety and supply of plasma-derived hemophilia products. It outlines how fractionation advances in the 1960s-1970s enabled treatment to free hemophiliacs. Both plasma-derived and recombinant products are important, with no single supply sufficient. Industry standards have reduced pathogen risks through donor selection, testing, and viral clearance steps. Emerging pathogens like West Nile virus require ongoing vigilance. While risks are low, vCJD transmission through plasma products remains a concern addressed through geographic deferrals and manufacturing clearance. Increasing global product demand challenges adequate supply for all patients.
The document discusses recent advances in pharmacy, including balloon angioplasty using bio-absorbable stents, nerve regeneration through identification of a protein that allows nerve growth, a cancer spit test that detects tumor DNA in saliva, and nano cosmeceuticals and topical delivery systems for phytochemicals. It also discusses anti-Parkinson activity of a plant extract from Ficus religiosa leaves.
This document provides summaries of various studies on the health effects of electromagnetic fields (EMF) and radiofrequency (RF) radiation from sources like mobile phones, mobile phone base stations, and wireless internet routers. It summarizes 12 studies from 2011-2012 investigating topics like the impact of EMF on melatonin levels, DNA damage, cognitive performance, stress and sleep, fertility and sperm health, and brain tumor risk in children. The studies were conducted in several countries and investigated biological effects in humans and animals as well as epidemiological associations with mobile phone use.
Inovio is developing DNA-based immunotherapies and vaccines to treat cancer and infectious diseases. Their lead product VGX-3100 met primary and secondary endpoints in a Phase II cervical dysplasia trial. Inovio has multiple cancer and infectious disease products in development and partnerships with AstraZeneca and Roche worth over $1 billion in potential milestones. They are pursuing DNA-based monoclonal antibody products and have over $100 million in non-dilutive funding supporting their vaccine programs.
Robots may become heroes in war on coronavirusmyrobostation
Robots were used in a temporary hospital in Wuhan to serve meals, take temperatures, and keep patients entertained. Doctors remotely controlled robots to reduce risk to healthcare workers. Now, robots deliver medicine and meals to isolated patients in hospitals. Hospitals are also using robots to continuously disinfect rooms and common areas to help eliminate viruses and bacteria. The pandemic is accelerating the use of robots for tasks like scanning crowds for possible COVID-19 symptoms from a distance.
Lensar's laser system has been cleared by the FDA for performing arcuate incisions during cataract surgery. With this clearance, Lensar's laser system can now perform corneal and arcuate incisions as well as lens fragmentation and anterior capsulotomy procedures. The clearance expands the capabilities of Lensar's laser system and strengthens its position as a provider of advanced laser technology for cataract surgery. Lensar expects the new indication to drive adoption of its system by both new and existing customers.
At Auto Mobile is the best driving school in Long Island, We provide driving classes, education, road test preparation and defensive driving course to Long Island Queens and all over New York. For More Info Visit http://www.autocluboflongisland.com/driving-school-in-queens
New 2014 Subaru BRZ Premium For Sale In Tucson, AZmixchalina
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
El documento es una lista de saludos dirigidos a objetos comunes de una escuela, incluyendo una computadora, calculadora, mochila, silla, papel, lápices de color, lápiz, pega y marcadores.
This document discusses the apparent suicide of Amanda Starnes on July 23, 2007 after being encouraged to harm herself by someone on MySpace. It provides details about her death and the outpouring of grief from friends and family. However, it then reveals that the whole story was a hoax and Amanda is in fact still alive, as a way to teach people a lesson about how to treat others with respect.
Plan de la Patria 2013-2019 Asamblea Nacionaljoseluisjornada
Este documento presenta el Segundo Plan Socialista de Desarrollo Económico y Social de la Nación de Venezuela para 2013-2019. El plan se basa en la visión a largo plazo establecida en documentos anteriores como la Agenda Alternativa Bolivariana de 1996 y el primer Plan Socialista, con el objetivo final de establecer la República Bolivariana para el año 2019 basada en la justicia social.
Catalyst DNA is a creative agency formed in 2002 that provides branding, graphic design, digital services, and web development. They have a team of senior creative and technical experts located in Dublin and other cities. Their core clients include Aviva, AA, Enterprise Ireland, and Eirgrid. They provide services such as branding, advertising, digital work, print management, and web/app development. They can turn around creative work within 1-3 days for rush jobs or 1 week for larger projects. Pricing for their services ranges from €80-150 per hour depending on the role.
The document summarizes observations from a small Armenian Orthodox Christian baptism ceremony for two older children. Only close family and friends attended the brief ceremony at St. Peter's Church in Hollywood. The priest arrived and led the ritual blessings as the godparents participated, before pictures were taken and the small gathering concluded with a meal at the children's home.
El documento lista los nombres de nueve integrantes que tomaron fotos de la geometría en la cuidad para un proyecto escolar. Los integrantes incluyen a Chico María Jimena, Córdoba Belinda del Rosario, Díaz Carla Sabina, Ituarte Jesús Emiliano, Juárez Viviana del Valle, Márchese Verónica Julieth, López Juan Fernando, Racedo María Antonella y Santilli Romina Verónica.
- The document outlines the rules for a game called "Bluff!" where teams answer questions to earn points.
- It provides 22 questions about ancient Mesopotamian civilizations like Sumer, Babylon, Assyria as well as Egypt, Phoenicia, and Israel.
- The questions cover topics like polytheism, the Fertile Crescent environment, myths, empires, important rivers, alphabets, trade, famines, laws, and religious beliefs.
1. A bus driver parks under a sad tree and talks to it, learning that children have been harming it by cutting its leaves, flowers, and fruits.
2. A teacher then takes students to explain the benefits of trees, like providing shade, fruits, oxygen, and medicine.
3. All the objects around, like chairs, pencils, and plants, listen. When rain starts, they go inside but the objects begin talking to each other.
4. The tree assigns jobs like making banners and food to the objects to plan an event to teach others about saving trees.
Nanotechnology is the science of understanding, inventing, and controlling objects which are built in the scales of nanometers (one nanometer is one-billionth of a meter). Using Nanotechnology, manufacturers can compose components such as batteries, robots, or tools at a very small scale which may be later added to medical devices. With advanced scientific developments over a decade, Nanotechnology is proving itself to be useful in the healthcare domain including alternative drug production, cosmetic products, and medical devices. As, in such cases, human safety is the highest priority, these devices or applications which utilize Nanotechnology should be FDA compliant before they are marketed for use...
Human Ad-5 based FMD vaccines (T. de Los Santos)EuFMD
The European Commission for the Control of Foot-and-Mouth Disease (EuFMD), one of FAO’s oldest Commissions, came into being on the 12th June 1954, with the pledge of the sixth founding member state to the principles of a coordinated and common action against Foot-and-mouth Disease.
The document discusses the safety and supply of plasma-derived hemophilia products. It outlines how fractionation advances in the 1960s-1970s enabled treatment to free hemophiliacs. Both plasma-derived and recombinant products are important, with no single supply sufficient. Industry standards have reduced pathogen risks through donor selection, testing, and viral clearance steps. Emerging pathogens like West Nile virus require ongoing vigilance. While risks are low, vCJD transmission through plasma products remains a concern addressed through geographic deferrals and manufacturing clearance. Increasing global product demand challenges adequate supply for all patients.
The document discusses recent advances in pharmacy, including balloon angioplasty using bio-absorbable stents, nerve regeneration through identification of a protein that allows nerve growth, a cancer spit test that detects tumor DNA in saliva, and nano cosmeceuticals and topical delivery systems for phytochemicals. It also discusses anti-Parkinson activity of a plant extract from Ficus religiosa leaves.
This document provides summaries of various studies on the health effects of electromagnetic fields (EMF) and radiofrequency (RF) radiation from sources like mobile phones, mobile phone base stations, and wireless internet routers. It summarizes 12 studies from 2011-2012 investigating topics like the impact of EMF on melatonin levels, DNA damage, cognitive performance, stress and sleep, fertility and sperm health, and brain tumor risk in children. The studies were conducted in several countries and investigated biological effects in humans and animals as well as epidemiological associations with mobile phone use.
Inovio is developing DNA-based immunotherapies and vaccines to treat cancer and infectious diseases. Their lead product VGX-3100 met primary and secondary endpoints in a Phase II cervical dysplasia trial. Inovio has multiple cancer and infectious disease products in development and partnerships with AstraZeneca and Roche worth over $1 billion in potential milestones. They are pursuing DNA-based monoclonal antibody products and have over $100 million in non-dilutive funding supporting their vaccine programs.
Robots may become heroes in war on coronavirusmyrobostation
Robots were used in a temporary hospital in Wuhan to serve meals, take temperatures, and keep patients entertained. Doctors remotely controlled robots to reduce risk to healthcare workers. Now, robots deliver medicine and meals to isolated patients in hospitals. Hospitals are also using robots to continuously disinfect rooms and common areas to help eliminate viruses and bacteria. The pandemic is accelerating the use of robots for tasks like scanning crowds for possible COVID-19 symptoms from a distance.
Lensar's laser system has been cleared by the FDA for performing arcuate incisions during cataract surgery. With this clearance, Lensar's laser system can now perform corneal and arcuate incisions as well as lens fragmentation and anterior capsulotomy procedures. The clearance expands the capabilities of Lensar's laser system and strengthens its position as a provider of advanced laser technology for cataract surgery. Lensar expects the new indication to drive adoption of its system by both new and existing customers.
At Auto Mobile is the best driving school in Long Island, We provide driving classes, education, road test preparation and defensive driving course to Long Island Queens and all over New York. For More Info Visit http://www.autocluboflongisland.com/driving-school-in-queens
New 2014 Subaru BRZ Premium For Sale In Tucson, AZmixchalina
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
El documento es una lista de saludos dirigidos a objetos comunes de una escuela, incluyendo una computadora, calculadora, mochila, silla, papel, lápices de color, lápiz, pega y marcadores.
This document discusses the apparent suicide of Amanda Starnes on July 23, 2007 after being encouraged to harm herself by someone on MySpace. It provides details about her death and the outpouring of grief from friends and family. However, it then reveals that the whole story was a hoax and Amanda is in fact still alive, as a way to teach people a lesson about how to treat others with respect.
Plan de la Patria 2013-2019 Asamblea Nacionaljoseluisjornada
Este documento presenta el Segundo Plan Socialista de Desarrollo Económico y Social de la Nación de Venezuela para 2013-2019. El plan se basa en la visión a largo plazo establecida en documentos anteriores como la Agenda Alternativa Bolivariana de 1996 y el primer Plan Socialista, con el objetivo final de establecer la República Bolivariana para el año 2019 basada en la justicia social.
Catalyst DNA is a creative agency formed in 2002 that provides branding, graphic design, digital services, and web development. They have a team of senior creative and technical experts located in Dublin and other cities. Their core clients include Aviva, AA, Enterprise Ireland, and Eirgrid. They provide services such as branding, advertising, digital work, print management, and web/app development. They can turn around creative work within 1-3 days for rush jobs or 1 week for larger projects. Pricing for their services ranges from €80-150 per hour depending on the role.
The document summarizes observations from a small Armenian Orthodox Christian baptism ceremony for two older children. Only close family and friends attended the brief ceremony at St. Peter's Church in Hollywood. The priest arrived and led the ritual blessings as the godparents participated, before pictures were taken and the small gathering concluded with a meal at the children's home.
El documento lista los nombres de nueve integrantes que tomaron fotos de la geometría en la cuidad para un proyecto escolar. Los integrantes incluyen a Chico María Jimena, Córdoba Belinda del Rosario, Díaz Carla Sabina, Ituarte Jesús Emiliano, Juárez Viviana del Valle, Márchese Verónica Julieth, López Juan Fernando, Racedo María Antonella y Santilli Romina Verónica.
- The document outlines the rules for a game called "Bluff!" where teams answer questions to earn points.
- It provides 22 questions about ancient Mesopotamian civilizations like Sumer, Babylon, Assyria as well as Egypt, Phoenicia, and Israel.
- The questions cover topics like polytheism, the Fertile Crescent environment, myths, empires, important rivers, alphabets, trade, famines, laws, and religious beliefs.
1. A bus driver parks under a sad tree and talks to it, learning that children have been harming it by cutting its leaves, flowers, and fruits.
2. A teacher then takes students to explain the benefits of trees, like providing shade, fruits, oxygen, and medicine.
3. All the objects around, like chairs, pencils, and plants, listen. When rain starts, they go inside but the objects begin talking to each other.
4. The tree assigns jobs like making banners and food to the objects to plan an event to teach others about saving trees.
This article examines the impact of plyometric training on physical fitness variables among ball badminton players. 30 male ball badminton players between 18-25 years of age were randomly assigned to an experimental or control group. The experimental group underwent 6 weeks of plyometric training while the control group received no training. Testing was conducted before and after the training period to assess muscular endurance and speed. Statistical analysis found significant improvements in muscular endurance and speed for the experimental group compared to the control group, supporting the hypothesis that plyometric training positively impacts physical fitness variables important for ball badminton performance.
The DotCom Bubble in California occurred from 1997-2000 and was marked by the rapid founding and speculative public stock listings of many new Internet companies. The NASDAQ index peaked in March 2000 before losing half its value by the end of the year as the bubble burst. As the bubble deflated in 2001, many dotcom companies stopped trading or failed altogether. The bubble's bursting led to an economic recession in the US and other countries in the early 2000s and demonstrated how overestimation and speculation can cause market collapses.
Dokumen tersebut membahas pengelompokan unsur kimia menurut beberapa ilmuwan sejarah seperti Lavoisier, Dobereiner, Newlands, dan Mendeleev. Lavoisier membagi 33 unsur menjadi 4 kelompok pada 1789. Dobereiner mengelompokan unsur berdasarkan kemiripan sifatnya menjadi kelompok triade pada 1829. Newlands mengelompokan unsur berdasarkan kenaikan massa atom relatif dan memperkenalkan hukum oktaf. Mendeleev men
El documento habla de un viaje a la India el 2 de junio de 2009. Menciona la fecha y hora actual y anima al lector a relajarse y darse una vuelta por la India.
The film targets young urban males by depicting a low-budget British drama about a group of skaters dealing with drugs, relationships, and urban struggles. It uses grime music by No Mannerz to draw in this audience. Skating stunts performed by non-professionals aim to feel authentic to skaters. The opening takes influence from This is England by using stills and footage to set the urban setting and atmosphere.
Uso e Importancia de las Aplicaciones que Ofrece Internet en la Educación.Elisa Telles
En esta presentación se dá un resumen, de la importancia que puede tener el uso del internet en los salones de clase o fuera; tambien sus ventajas y desventajas.
Sepsis is a serious medical condition caused by the body's response to an infection. It affects over 1.5 million people per year in the US and EU, with a mortality rate of 25-30%. Rapid diagnosis is key to treatment, which involves intensive care and can cost over €2,500 per day. Existing diagnostic tests are inadequate. Precysion is developing a new diagnostic tool using genetic biomarkers to predict sepsis risk before symptoms occur, enabling optimized individual treatment. It has the potential to save lives, reduce healthcare costs, and address a multi-billion euro market.
The document is a consensus statement from UK and international medical and scientific experts expressing serious concerns about the health effects of non-ionizing radiation and calling for urgent action. It summarizes evidence that radiofrequency radiation (RFR) has been proven to damage biological systems and increase health risks like cancer. While current safety guidelines are inadequate, some countries have adopted stricter limits and taken steps to reduce exposures, especially for children. The statement calls for an immediate moratorium on 5G and other new RFR sources until independent health research is done and biologically safe public limits are established.
The Detection and Identification of Infectious Agents Innovation Platform aims to encourage the development, uptake and adoption of clinically useful and commercially viable diagnostics for detecting infectious agents in humans and animals. The Technology Strategy Board launched the platform in 2008 and will invest up to £50 million over five years, together with additional funding from government departments like the Department of Health. More rapid and accurate diagnosis of infectious diseases can lead to targeted treatments that reduce the social and economic impact of diseases and create opportunities for UK industry.
Coronavirus disease (COVID-19) is a pandemic disease, which has already caused
thousands of causalities and infected several millions of people worldwide. Any technological tool
enabling rapid screening of the COVID-19 infection with high accuracy can be crucially helpful to the
healthcare professionals. The main clinical tool currently in use for the diagnosis of COVID-19 is the
Reverse transcription polymerase chain reaction (RT-PCR), which is expensive, less-sensitive and requires
specialized medical personnel. X-ray imaging is an easily accessible tool that can be an excellent alternative
in the COVID-19 diagnosis. This research was taken to investigate the utility of artificial intelligence (AI)
in the rapid and accurate detection of COVID-19 from chest X-ray images
Role of In Vitro Diagnostics in Saudi ArabiaSolidiance
Saudi Arabia’s healthcare system currently relies heavily on government funding, which accounts for 65% healthcare spending in the country. Healthcare trends in Saudi Arabia's, e.g. demographic shifts, high incidence rates of lifestyle related diseases, growing demand for private healthcare services, and strategic investments made by the government have driven demands for in vitro diagnostic (IVD) devices. Solidiance co-developed this exclusive white paper with Kind Abdulaziz Medical City and Abbott Diagnostics, highlighting the contribution, value and future of in vitro diagnostics in Saudi Arabia’s healthcare system. According to the report, the future looks bright for IVD in Saudi Arabia, however it depends on how fast it can be adopted and implemented in order to benefit the government, healthcare players seeking to improve and invest on the sector, and also the people.
Optical sensing techniques for quality control of cathetersmbaltazar
This document discusses using optical spectroscopy techniques like reflectance spectroscopy for quality control testing of antimicrobial coatings on catheters. It describes how one catheter manufacturer is using an Ocean Insight spectrometer setup to measure coating concentration and uniformity onsite, providing a faster and less destructive alternative to traditional HPLC testing. The spectrometer measurements showed high correlation to HPLC results, demonstrating its effectiveness for ensuring catheter coating quality meets standards. Preventing device infections is important for patient safety and reducing healthcare costs.
09 CeoMeeting- Session 4- Medicines for MalariaMLSCF
The document discusses product development partnerships (PDPs) that work to develop medicines and treatments for diseases that disproportionately impact developing countries and have limited commercial incentives. It provides Medicine for Malaria Venture (MMV) as a key example of a PDP focused on developing antimalarial drugs. MMV has developed over a dozen antimalarial candidates and products over its existence, including a pediatric-friendly version of Coartem through partnerships with Novartis. PDPs have grown substantially over the past decade and play a central role in driving neglected disease product pipelines.
The document summarizes news from the medical device industry. Specifically, it discusses:
1) The FDA clearance of Lumendi's Dilumen endoscopic accessory, which uses balloons to help position an endoscope and treat colonic lesions. This represents a minimally invasive alternative to surgery.
2) Varian Medical Systems' plan to spin off its imaging components business to boost its valuation after a difficult year.
3) Continued growth in patent filings from China, including in medical devices, cementing its status as an innovation leader according to the World Intellectual Property Organization.
4) Blackfynn's neurology data platform that aims to advance research by aggregating data, with
BreatheSuite is a medical device startup that has developed a smartphone-based spirometer to diagnose respiratory diseases like asthma and COPD. It was founded by three graduate students and has advisors from UW Medicine and global health non-profits. BreatheSuite aims to improve diagnosis of respiratory diseases globally by making low-cost spirometry accessible on any phone. Clinical trials have found BreatheSuite results are identical to traditional spirometers. It sees market opportunities in pharmaceutical clinical trials, developing countries, and existing customers include global health non-profits.
This poster summarizes results presented at the 2010 American Society of Blood and Marrow Transplantation meeting comparing outcomes of two stem cell transplantation trials for acute myeloid leukemia patients. The trials utilized either T-cell depleted grafts (TCD) after CD34+ selection or unmodified grafts. While disease-free survival, overall survival, and transplant-related mortality were similar between the groups, the TCD group had significantly lower rates of acute graft-versus-host disease (20% vs 38%) and chronic GVHD (19% vs 47%) without increased relapse risk. The results support T-cell depletion in matched transplantation and suggest its extension to matched unrelated transplantation.
INSIGHT ABOUT DETECTION, PREDICTION AND WEATHER IMPACT OF CORONAVIRUS (COVID-...ijaia
The document summarizes research using machine learning models to analyze the impact of weather factors on the COVID-19 pandemic and to detect COVID-19 from chest X-rays. It describes using decision tree regressors to determine that temperature, humidity, and sun exposure have 85.88% impact on COVID-19 spread and 91.89% impact on COVID-19 deaths. It also details using pre-trained convolutional neural networks like VGG16 and VGG19 on chest X-rays to classify images as normal, pneumonia, or COVID-19 with over 92% accuracy. Finally, it mentions using logistic regression to predict an individual's risk of death from COVID-19 based on attributes like age, gender, and location, achieving 94.
Eskulabs is developing an AI-based platform to store and analyze medical images. The platform will allow doctors to upload images and videos of patient organs over time. AI and computer vision tools will recognize images to enable early disease diagnosis. This will help detect malignancies earlier. The platform aims to improve on current challenges with medical image storage and analysis by providing a unified format for dynamic comparison of images across devices and specialists. This could help with early detection of disease progression and risk prediction.
The document discusses the current state and expected growth trends of the in vitro diagnostics (IVD) market. It notes that the global IVD market was estimated at $54.2 billion in 2013 and is expected to grow 4% annually to $64.3 billion by 2018. Technological advances in areas like genomics, bioinformatics, and miniaturization have transformed diagnostic laboratory technology in recent years. Personalized medicine, infectious disease testing, and other applications are driving growth in the IVD market. However, economic instability, rising healthcare costs, and reimbursement changes pose challenges for the industry.
The World Malaria Report 2022 provides an overview of global and regional malaria trends and the status of malaria control efforts worldwide. It finds that despite disruptions from COVID-19, most malaria-endemic countries were able to maintain malaria services in 2021. However, over 600,000 people still die from malaria each year, most of them children. Progress against malaria faces risks such as antimalarial drug and insecticide resistance. The report also outlines new WHO guidance and initiatives to strengthen malaria programs and containment strategies. It examines the malaria product pipeline and need for increased investment in research and development of new tools.
N8 Biosciences is developing antimicrobial medical devices and treatments using its patented Ceragenin platform. Its lead product is a endotracheal tube coated with CSA-131 which has received approval in Canada and is proven to reduce bacterial colonization by 97% in studies. The company has a pipeline of additional medical devices and is exploring opportunities in conditions like cystic fibrosis, multiple myeloma and gastric cancer where CSA compounds have shown promise in preclinical research. N8's strategy involves both direct commercialization of medical devices and partnering with industry for joint development opportunities across areas of unmet need in hospital acquired infections.
InSightec was founded in 1999 and develops the ExAblate system for non-invasive MR-guided focused ultrasound treatment of cancers and tumors. Over 80 ExAblate systems have been installed worldwide and used to treat over 6000 patients for conditions like uterine fibroids. InSightec's non-invasive treatments provide benefits to patients like short recovery times and reduced side effects compared to alternative invasive procedures.
1. The document provides an update on evidence for the use of the InteguSeal® microbial sealant to reduce surgical site infections following cardiac surgery.
2. Two studies were included in the update - a randomized controlled trial and a pseudo-randomized controlled trial comparing the sealant to standard cleaning and draping.
3. The sealant forms a continuous, breathable barrier on the skin to immobilize bacteria and prevent migration into incision sites, with the goal of reducing surgical site infections.
The B-Safe system aims to prevent the spread of viruses like HIV and hepatitis C among intravenous drug users. It consists of a portable case containing a syringe that is sanitized using ultraviolet-C light. When a user closes the case for five minutes after injecting, the light deactivates viruses in the syringe that may be transmitted if the syringe is reused. The system seeks to address the risks of blood residue remaining in reused syringes. Current prototypes need further development and testing before the cases can be distributed to active drug users for real-world testing of effectiveness and usability.
While many companies are contributing to the battle against the pandemic, Deep Tech startups are trying to overcome scientific challenges to help with prevention, testing or treatment in novel and scalable ways.
This live event organized by SOSV brings together investors who have backed dozens of relevant startups, to get a sense of:
- The variety of solutions being developed,
- Their potential outcomes,
- The broader role and opportunities of deep tech investment.
SPEAKERS
- Seth Bannon, Founding Partner, Fifty Years
- Jun Axup, PhD, Chief Science Officer & Partner, IndieBio / SOSV
- Alex Morgan, MD PhD, Partner, Khosla Ventures
MODERATORS
- Julie Wolf, PhD, Communications Director, IndieBio / SOSV
- Benjamin Joffe, Partner, SOSV
COVID-19 PORTFOLIO
- Fifty Years: www.fifty.vc/covid
- SOSV: www.sosv.com/covid-startups/
- Khosla Ventures: www.khoslaventures.com/khosla-ventures-entrepreneurs-are-responding-with-amazing-diversity-to-covid-19-solutions-for-societys-needs
Similar to Executive Summary 2009 Project Continuation With Pics (20)
Executive Summary 2009 Project Continuation With Pics
1. Company Statement GlobalMed Technologies Inc. was incorporated in the State of Florida on April 9th, 2002 for the purpose of manufacturing and distributing a patented state of the art Ultraviolet Light Blood Irradiation System for the treatment of HIV/AIDS. After two decades of the HIV/AIDS pandemic, an estimated eight out of nine people with the detectable HIV virus have developed resistance to at least one drug in the HIV/AIDS medicine cabinet, i.e. the “retrovirals”, and from 20 to 60% of infected patients have exhausted drugs in at least two of the three classes of HIV medicines currently in use. (Annex # 1) 19050209550Western & Central Europe760 000[600 000 – 1.1 million]Middle East&North Africa380 000[270 000 – 500 000]Sub-Saharan Africa22.5 million[20.9 – 24.3 million]Eastern Europe & Central Asia1.6 million [1.2 – 2.1 million]South & South-East Asia 4.0 million [3.3 – 5.1 million]Oceania75 000[53 000 – 120 000]North America1.3 million[480 000 – 1.9 million]Latin America1.6 million[1.4 – 1.9 million]East Asia800 000[620 000 – 960 000]Caribbean230 000[210 000 – 270 000]UNAIDS and CNN Special World Health, both report approximately 36,000,000 HIV afflicted people worldwide (See Annex # 2) and although hundreds of millions of dollars have been spent in search of a cure, no effective solution has been found. Retroviral medications have side effects so severe that many HIV/AIDS patients refuse to take the medication. (Annex # 3) -184785064770Total: 33.2 (30.6 – 36.1) million The HIV virus in a thirty six hour period (36 hours) can replicate itself approximately 800 million times. Of these copies 75% will find target CD4 cells and each one will in a thirty six hour period produce 800 million more copies. After 7 to 10 years, the person’s infected immune system will be near total collapse. Add to this the mutations which develop during replication and we can understand why the development of a vaccine is not possible. (Annex # 4) 4105275857255476875142875People newly infected with HIV in 2007 4010025250825Total 2.7 million [2.2 – 3.2 million]Adults 2.3 million [1.9 – 2.8 million]Children under 15 years 370 000 [330 000 – 410 000]The implications are dire: A virus that once seemed on the verge of containment is beyond the reach of medications that promised to transform HIV/AIDS into a chronic but treatable condition. In the last 4 years nearly 12 million new cases of AIDS were reported. (See Annex # 5) GlobalMed Technologies has developed an effective treatment modality for HIV/AIDS and other blood-borne diseases, utilizing ultraviolet irradiation, which is safe, efficient, and has minimal side effects. In Government Approved Clinical Trials performed in 2004 in the Dominican Republic, viral load counts in 36 subjects were reduced by 84-99% within 90 days. CD4 cell counts remained stable and life expectancy increased tenfold. (Annex # 6) The current U.S. costs to treat an HIV/AIDS patient, with retroviral medication, ranges from $12,000 to $48,000 per year. Add to this the costs of opportunistic infection medications, hospitalization, diagnostic testing, laboratory tests, infusion therapy, home care therapy, plus all the administration costs and the yearly total for a chronic carrier is approximately $200,000 per year. (Annex # 7) Besides the efficiency of the GMT Process there is an added benefit, we can Decrease Costs Across the Board by 75% in the first year, 80% in the second year and 90% in the third year. We can save insurance companies billions in revenue per year and offer a viable solution to the HIV/AIDS Pandemic. 5810250257175Background Orientation The father of Phototherapy is Dr. Niels Finsen from Denmark, and who treated 300 patients who suffered from Lupus Vulgari. He obtained a 100% curative rate, and thereby was awarded the Nobel Prize in Physiology and Medicine in 1903. (See Annex # 8). 7620034290America would not enter this field of medicine until the 1920’s and 1930’s, when a Scientist by the name of Dr. Emmet Knott, from Seattle (See Annex 9) sought to harness the known bactericidal property of ultraviolet rays in order to treat infectious diseases of the blood. Knott built an apparatus known as the “Knott Irradiator” that would remove a small amount of blood from the body through an IV tube, citrate it to avoid coagulation, expose it in a small chamber to calibrated UV irradiation, and then infuse it back into the body through the same IV tube. 76200245745The FDA has approved only one Photopheresis machine in the united states, that of a company called THERAKOS, a subsidiary of Johnson & Johnson. Dr. Eldeson of THERAKOS developed a Extracorporeal Photopheresis Blood Irradiator. They were granted preliminary certification to performed clinical trial studies with HIV and Graft Host Diseases. (Annex # 10, 11). 5810250196850 Studies which were performed by Columbia University’s Photopheresis Unit in Morristown NY demonstrated that 4 of 7 patients (57%) with HIV/AIDS became SERO NEGATIVE after 5 to 19 treatments and remained so for 14 to 16 months after the termination of the study. In an extended trial several years later 17 of 19 patients became SERO NEGATIVE. (Annex # 12, 13) This treatment modality with its long existence and proven record throughout the US and Europe could be a beneficial tool in modern medicine. If applied properly, Hemoirradiation is an answer to today’s world pandemics 755651631955543550163830 Dr. Fernandez GMT’s Founder, designed “THE PCI-1” Hemoirradiator, along with the“GMT-Disposable Kit” and the GMT-Cuvette, which acts as the irradiation chamber during treatment. 76200186690It has taken Dr. Fernandez 12 years of research, development and testing to establish the correct intensity, time of exposure volume, flow rate, and process of irradiation. When applied within standards it guarantees a precise dosage of UV Irradiation that only destroys the invading organisms and leaves unharmed the surrounding tissues, blood and serous components. Side effects are minimal and transitory. (See Annex #14) The GMT-PCI-1; 3876675482601 Measures and displays the precise time of irradiation. 2 Measure, vary and display the intensity of the beam of light. 3 Adjust and display the precise amount of UV dosage. 4 Allow for the use and variance of a narrow or wide wave band of light. 5 Measure and display the precise flow rate for any given Volume of Blood. 6 Computer Interfaced with Print capabilities. 7 Proprietary Software which generates detailed reports of all data acquired. 8 Measures the amount and flow of blood irradiated. 9 Barcode Scanneing, assures single use of GMT-Kit and Cuvette. 10 Patient Prescription Memory Chip (PPMC). 11 PPMC stores all patient treatment sessions and dosages. 12 Controls the UV energy needed for each specific blood borne virus, fungus or bacteria. 13 Internet Interfaced for downloading of clinical trials data. 17145038100The GMT-PCI-1 design will include a component that will deactivate all electronics within the machine if tampered with in any manner whatsoever. This design and safeguard feature will assist to prevent the GMT-PCI-1 from being reproduced or utilized for other purposes. 571500053530538100227330To date the company has raised three million dollars in the development and patenting of its products and process. The company requires the amount of $4 to $5 million dollars to enable it to reach its next phase in its development, which is, Phase Two Controlled Clinical Trials with 200 HIV/AIDS subjects. We are currently approved to perform said trials in the country of Colombia. We have Government, Academic Sponsorship from two universities, Laboratories, and the Government Public Hospital La Maria to carry out the trials. FUNDING-PHASE 2 CONTROL CLINICAL TRIALS IN 200 PEOPLE LIVING WITH HIV/AIDS. DESCRIPTIONPROFESSIONAL PERSONNEL$356,400.00GENERAL LAB TEST FOR 200 PATIENTS$400,000.00VIRAL LOAD LAB TESTS FOR 200 PATIENTS$360,000.00GENERAL SUPPLIES$50,000.00UNIVERSITY CES RESEARCHERS$100,000.00UNIVERSITY ANTIOQUIA RESEARCHERS$100,000.00INDEPENDENT BIO ETHIC COMMITTEE$100,000.00MISCELLANEOUS$133600.00TOTAL:$1,500,000.00 FUNDING GLOBALMED TECHNOLOGIES DESCRIPTIONPROFESSIONAL PERSONNEL$720,000.00OVERHEAD EXPENDITURES$400,000.00MARKETING-LOBBYING-CERTIFICATIONS$500,000.00VETINARY CLINICAL STUDY$250,000.00TOTAL:$1,870,000.00 FUNDING FOR LEGAL AND ADMINISTRATION DESCRIPTION$1,000,000.00LEGAL AND ADMINISTRATION COSTS$1,000,000.00GRAND TOTAL:$4,370,000.00 POSSIBLE SCENARIO TO GENERATE FUNDS WHILE CLINICAL STUDY IS IN PROGRESS. 5318760165105667375359410GlobalMed has established relationships with various insurance companies, government institutes and private entities which have demonstrated an interest to venture into an association with the company. GMT expects with the correct lobbying and marketing strategies we can be offering our services to the different health clinics, hospitals and institutes which treat HIV/AIDS patients. Currently in Colombia and most of Latin American, people with HIV/AIDS have demonstrated a resistance rate to retroviral medication between 60 to 85% This has burden the already strain economies in these countries. If someone could offer an effective treatment and lower costs at the same time, they would capture a niche in this hemispheres health market. 28575273685The Company anticipates in its strategies that it can commence selling GMT Kits and treatments to health clinics and hospitals while we conduct our clinical trials. By performing the appropriate lobbying we can convince the insurance companies in Colombia to pay for our treatments to patients who are resistant to the medications or those which are intolerant, due to their side effects. The percentage of people that fall into this category is 43% for the intolerants and 85% of those under government assistance. The total amount of HIV/AIDS cases in Colombia range between 190,000 to 300,000. Of these approximately 85,000 are being treated with retrovirals, of which 50% or 42.500 are either intolerant or resistant to the meds. (Annex # 15) These people have no hope since nothing works for them, but the government according to the Law 100 of the Health Code must provide medical attention and care. The amount of funds needed to keep these people alive is draining the governments throughout all of Latin America. By providing hope to a market which no pharmaceutical can get to and by lowering cost to the insurance companies and the government, our entry is but assured. GMT has done most of the legwork in this area and with the proper funding, lobbying and marketing we can expect to generate the funds below. The following table demonstrates the potential to generate income from the sales of kits in treatments performed at various health centers while clinical trials are in progress. POTENTIAL REVENUES DESCRIPTION NUMBER OF PATIENTSNUMBER OF KITS PER MO.NET REVENUES FROM THE SALE KITS/MONET REVENUES FROM THE SALE KITS/YR500 X 4 KITS/mo2,000$100,000$1,200,0001,0004,000$200,000$2,400,0001,5006,000$300,000$3,600,0002,0008,000$400,000$4,800,0003,00012,000$600,000$7,200,0004,00016,000$800,000$9,600,0005,00020,000$1,000,000$12,000,00010,00040,000$2,000,000$24,000,00015,00060,000$3,000,000$36,000,00020,00080,000$4,000,000$48,000,00025,000100,000$5,000,000$60,000,000 Committing to perform the clinical trials demonstrates a good will act on our behalf and opens the door for a profitable future. Now that Johnson and Johnson has commencement their clinical trials with irradiations in HIV/AIDS patients, the possibilities are endless. By going to South America and other countries first we guarantee a rapid approval. When we look at it from a business and benefit side, 99% of our market potential is outside the US, and we don’t need to perform clinical trials in the US to be approved worldwide. (Annex # 16) The process of approval in the US by the FDA is cumbersome and moves at a snail’s pace, something J&J has found out the hard way. Their first clinical pilot study was performed in 1990 at Colombia University Department of Photopheresis in Morristown New Jersey. They proved beyond a shadow of doubt that this process works by taking 4 subjects to sero negative. (Annex # 17) In 1992 they publish their second study results and 17 of 19 subjects reached sero negative. After these two studies were completed nothing is done by J&J in the field of HIV and Photopheresis until 2006, when Merck Sharpe and Dome announced that they were out of the vaccine race for HIV. They commented on the mutability of the HIV virus and how that made it impossible to develop a vaccine that could accommodate the genetically mutating changes of the virus and how fast it did so. (Annex # 18) This has opened the door for GMT and its process. We would be the first company to perform Controlled Clinical Trials in Various countries and certify a process of treatment which fights virus, bacteria’s, fungus and parasites effectively and viably. The next stage is Phase II Clinical Trials. During the ramp up phase and during the first six months of the clinical trials we will be marketing and lobbying all interested parties and other academics and government health officials to the benefits of this treatment. By the sixth month of clinical trials we should have acquired the first 500 to 1,000 patient in various clinics. These revenues would offset the revenues needed in the clinical trials. If we reach 5,000 patients we can literally pay for the development of not only Phase II but most of Phase III trials. We welcome any and all inquiries and we are prepared to attend any meeting where we may demonstrate the functionality of the PCI-1 and the GMT-Kit.